Loading company…
ValenTx develops nonsurgical medical devices and treatments for obesity and metabolic disorders.
Founded in Minnesota, US, in 2002, ValenTx develops medical devices and nonsurgical treatments for obesity and metabolic disorders, including type-2 diabetes and hypertension. Its endoluminal bypass therapy is designed to mimic anatomical changes from Roux-en-Y gastric bypass without surgery or gastric stapling.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in